Cash-Rich BioNTech Plans to Spend About $1 Bln More on Research This Year

BioNTech plans to spend up to about 1 billion euros ($1.1 billion) more on research and development and buy back up to $500 million more of its shares this year.
Reuters Health Information

source https://www.medscape.com/viewarticle/990191?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?